Location: Home
  • search
  • go
  • Relate News
  • 9/23/2025CMS and Generix Join Forces for Innovative Biologics
  • 9/23/2025China's Edge over U.S. Biotech Was Never Scientific (Washington Post)
  • 9/22/2025Marengo Launches Combined Phase II Trial of Invika and Trodelvy in Met...
  • 9/22/2025MagicRNA Publishes First-in-Human Data for In Vivo CAR-T Therapy in SL...
  • 9/22/2025Ascletis' ASC47 Combined with Semaglutide Shows Superior Weight Loss a...
  • 9/20/2025Ascletis and Sagimet's Acne Drug Demonstrates Rapid Efficacy in Chines...
  • 9/20/2025Recent Executive Moves
  • 9/19/2025Novartis Vows Greater Commitment to China Amid Innovation Surge
  • 9/19/2025GE HealthCare Explores Selling Stake in China Unit Amid Market Pressur...
  • 9/19/2025Lilly/Innovent's Mazdutide Approved in China for Type 2 Diabetes Glyce...
  • 9/19/2025​​​​​​​China Biopharma at Crossroads: A Mid-2025 Tale of Contra...
  • 9/18/2025Strengthening Oversight of Imported Drugs: Key Takeaways into New Regu...
  • 9/17/2025Two Chinese Biotechs File for IPOs in Hong Kong as Losses Mount but Pi...
  • 9/17/2025CDE Solicits Comments on Draft Guidance for mRNA Vaccine Research
  • 9/17/2025Mabwell and Aditum Form Kalexo Bio to Advance Innovative siRNA Therapy...
  • 9/17/2025HiDimond Bio Secures ~¥100M in Series Pre-A Funding
  • 9/16/2025Lion TCR Wins FDA Approval to Advance TCR-T Therapy for Chronic HepB
  • 9/15/2025Akeso's Cadonilimab and Pulocimab Combo Shows Promise in IO-Resistant ...
  • 9/15/2025Hengrui Files PCT Patent for Novel Amylin Analog with Dual Receptor Ac...
  • 9/15/2025BMS to Divest Majority Stake in Historic China JV to Hillhouse Capital
  • 9/15/2025Several Chinese Biotech Firms Added to U.S. Entity List Amid Security ...
  • 9/15/2025CSPC Receives Approval for Parkinson's Disease Drug Trial in China
  • 9/15/2025Chinese Biotech Startups Face Mixed Earnings amid Ambitious Global Exp...
  • 9/15/2025Merger Control in China's Healthcare Industry: Insights into Antitrust...
  • 9/13/2025NHSA Issues the Regulations on DRG/DIP Healthcare Security Payment Mec...
  • 9/12/2025The Rise of US-China Biotech Partnerships: Opportunities and Emerging ...
  • 9/12/2025CDE Solicits Comments on Draft Guidance for Insomnia Drug Clinical Tri...
  • 9/11/2025Chinese Biotechs Face Rising Hurdles in Advanced Therapies
  • 9/11/2025Novartis Gains Expanded Approval for Tabrecta in China
  • 9/11/2025RabPharma Raises Oversubscribed Series A++ to Push Ahead with RAB001d ...
  • Page:8/374 Total number of articles:11220: [First][<<] [6] [7] [8] [9] [10] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group